Suchergebnisse - "Buti, Maria"

PubPharm (16)

1

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2019

von Marcellin, P. | Wong, D. | Sievert, W. | +14

2

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy : a prespecified follow-up analysis of two randomised trials

enthalten in: The lancet. Gastroenterology & hepatology | 2019

von Buti, M. | Wong, D. | Gane, E. | +11

CommentIn: Lancet Gastroenterol Hepatol. 2019 Apr;4(4):260-262. - PMID 30795959

3

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

enthalten in: Journal of hepatology | 2018

von Agarwal, K. | Brunetto, M. | Seto, W. | +28

4

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B

enthalten in: Gut | 2017

von Bayliss, J. | Yuen, L. | Rosenberg, G. | +17

CommentIn: Gut. 2017 Jul;66(7):1349. - PMID 27797942

5

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2017

von Jacobson, I. | Washington, M. | Buti, M. | +13

6

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B

enthalten in: Annals of hepatology | 2017

von Oyagüez, I. | Buti, M. | Brosa, M. | +2

7

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients : Validation of the Page-B Score to Predict Hepatocellular Carcinoma

enthalten in: Digestive diseases and sciences | 2017

von Riveiro-Barciela, M. | Tabernero, D. | Calleja, J. | +20

8

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection : a randomised, double-blind, phase 3, non-inferiority trial

enthalten in: The lancet. Gastroenterology & hepatology | 2016

von Buti, M. | Gane, E. | Seto, W. | +20

CommentIn: Lancet Gastroenterol Hepatol. 2016 Nov;1(3):174-175. - PMID 28404084

9

Tenofovir discontinuation after long-term viral suppression in HBeAg negative chronic hepatitis B. Can HBsAg levels be useful?

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2015

von Buti, M. | Casillas, R. | Riveiro-Barciela, M. | +5

10

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

enthalten in: Hepatology international | 2015

von Buti, M. | Fung, S. | Gane, E. | +12